1 citations
,
May 2010 in “Nursing Standard” Treatments for autoimmune hair loss have limited success and patients need emotional support and self-acceptance.
1 citations
,
January 2010 in “Journal of Bioscience and Bioengineering” Exosomes may offer new treatments for hair loss.
1 citations
,
January 1986 in “PubMed” The boy's symptoms suggest a possible new medical condition.
1 citations
,
December 1982 in “PubMed” Sodium valproate effectively reduces seizures in children with epilepsy, especially in primary generalized cases.
June 2026 in “Dermatology and Therapy” Ritlecitinib provides new treatment options for diverse alopecia areata patients.
June 2026 in “Current Opinion in Pediatrics” Early, tailored assessment and treatment are crucial for adolescent hair loss, with promising new diagnostic and treatment options.
April 2026 in “AMEI's Current Trends in Diagnosis & Treatment” PCOS-related infertility is managed with lifestyle changes and medications.
April 2026 in “International Journal of Homoeopathic Sciences” Homeopathic treatment improved stress-induced hair loss in an 18-year-old female.
March 2026 in “Acta Dermato Venereologica” Lower illness acceptance is linked to more body dysmorphic disorder symptoms in patients with body modifications.
March 2026 in “Anais Brasileiros de Dermatologia” Facial aesthetic procedures improve quality of life for transgender individuals.
February 2026 in “Expert Review of Endocrinology & Metabolism” Early identification and personalized treatment of skin issues in PCOS are crucial for better outcomes.
February 2026 in “Psychoneuroendocrinology” Lower family income is linked to more stress in parents and more behavior problems in children.
Gender-diverse individuals face more depression and anxiety, possibly due to unique stress profiles.
February 2026 in “Journal of Drugs in Dermatology” Janus kinase inhibitors are effective and safe for treating alopecia areata.
January 2026 in “Dermatology Practical & Conceptual” Diffuse lichen planopilaris greatly reduces quality of life.
January 2026 in “AIMS Public Health” Digital health education may reduce stress, anxiety, and depression in PCOS patients.
January 2026 in “Journal of Case Reports and Scientific Images” Homeopathic treatment may help manage alopecia areata by considering the whole person.
December 2025 in “Journal of Education Health and Sport” LED therapy is safe and effective for improving skin health and appearance.
December 2025 in “Journal of Cosmetic Dermatology” Finasteride does not increase the risk of depression or suicide.
December 2025 in “Meditsinskiy sovet = Medical Council” Early diagnosis and multidisciplinary care are crucial for managing CNOT3 syndrome.
December 2025 in “BJPsych Open” Semaglutide may worsen eating disorders in vulnerable individuals.
November 2025 in “Frontiers in Psychiatry” People with androgenetic alopecia often experience more anxiety, depression, and lower self-esteem.
November 2025 in “Journal of the European Academy of Dermatology and Venereology” JAK inhibitors may reduce depression in people with alopecia areata.
November 2025 in “Skin Health and Disease” Addressing alexithymia can improve anxiety and depression in alopecia areata patients.
November 2025 in “Journal of Laboratory Medicine” Chronic stress increased after lockdown, especially in young adults and females.
November 2025 in “Emergency Medicine News” Use correct terms and show sensitivity to improve transgender care in emergency departments.
October 2025 in “World Journal of Biology Pharmacy and Health Sciences” Hormonal imbalances can cause acne, excess hair growth, and hair loss in women, needing combined medical and emotional care.
October 2025 in “COGNITIONIS Scientific Journal” Postpartum hair loss is common, temporary, and linked to hormonal changes, stress, and nutrition.
October 2025 in “Experimental & Molecular Medicine” Hair analysis is valuable for health and forensics but faces challenges like growth variability and contamination.
October 2025 in “Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)” A incongruência de género, quando associada a sofrimento, é conhecida como disforia de género, afetando cerca de 2% da população mundial em 2024. As intervenções terapêuticas, essenciais para essas condições, incluem transição social e médica, com tratamentos hormonais específicos para adolescentes e adultos. A terapia hormonal pode ser feminizante ou masculinizante, frequentemente complementada por cirurgia, para alinhar o corpo com a identidade de género. O farmacêutico desempenha um papel crucial na equipe multidisciplinar, oferecendo educação, aconselhamento e gestão da terapia. Evidências científicas indicam que essas intervenções melhoram significativamente a saúde mental, reduzindo a depressão e a disforia de género, além de aumentar a qualidade de vida.